VF
VIVO

Virtu Financial’s Meridian Bioscience Inc VIVO Stock Holding History

Virtu Financial’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,757
Closed -$418K – 2476
2022
Q2 		$418K Buy
+13,757
New +$372K 0.04% 438
2020
Q3 		– Sell
-10,616
Closed -$247K – 1691
2020
Q2 		$247K Buy
+10,616
New +$154K 0.03% 636

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial's VIVO Position: Q3 2022 in Review

Virtu Financial sold out of Meridian Bioscience Inc (VIVO) in Q3 2022, closing a stake of 13,757 shares — an estimated $418K sold.

Virtu Financial first reported a position in VIVO in Q2 2020 and held it in 2 quarters. The position peaked at $418K in Q2 2022. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.

  • Virtu Financial reported no remaining Meridian Bioscience Inc position as of Q3 2022 after selling out during the quarter.
  • Virtu Financial sold 13,757 Meridian Bioscience Inc shares in Q3 2022, an estimated $418K.
  • Virtu Financial first reported a position in Meridian Bioscience Inc in Q2 2020 and held it in 2 quarters.
  • Virtu Financial's Meridian Bioscience Inc position peaked at $418K in Q2 2022.
  • 203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.

Based on Virtu Financial's 13F filing for Q3 2022, filed 7 Nov 2022.